Cerebrospinal fluid GABA and homocarnosine concentrations in patients with Friedreich's ataxia, Parkinson's disease, and Huntington's chorea-Reference-Cited by-同舟云学术

Cerebrospinal fluid GABA and homocarnosine concentrations in patients with Friedreich's ataxia, Parkinson's disease, and Huntington's chorea

Published:1987 Issue:2 Volume:2 Page:117-123
ISSN:0885-3185
Container-title:Movement Disorders
language:en
Short-container-title:Mov Disord.

Author:

Bonnet A. M.,Tell G.,Schechter P. J.,Grove J.,Saint-Hilaire M. H.,De Smet Y.,Agid Y.

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Reference37 articles.

1. GABA levels in cerebrospinal fluid of patients with Huntington's chorea: A preliminary report

2. Cerebrospinal Fluid -Aminobutyric Acid Variations in Neurological Disorders

3. Cerebrospinal fluid GABA levels in Huntington's disease, ?at risk? for Huntington's disease and normal controls. In: and eds. Huntington's disease. New York: Raven Press, 1979: 547-56. (Advances in Neurology series: vol 23.).

4. Levels of -Aminobutyric Acid in Cerebrospinal Fluid in Various Neurologic Disorders

5. Choline acetylase and glutamic acid decarboxylase in Huntington's chorea: A preliminary study

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. State of the Art in the Development of Human Serum Carnosinase Inhibitors;Molecules;2024-05-24

2. Cerebrospinal Fluid Biomarkers in Huntington’s Disease;Contemporary Clinical Neuroscience;2023

3. Cerebrospinal and blood levels of amino acids as potential biomarkers for Parkinson’s disease: review and meta‐analysis;European Journal of Neurology;2020-09-11

4. Biofluid Biomarkers in Huntington’s Disease;Methods in Molecular Biology;2018

5. Cerebrospinal Fluid Biomarkers for Huntington’s Disease;Journal of Huntington's Disease;2016-03-31